BG33885A3 - Method for producing the amids of lisergine acid - Google Patents

Method for producing the amids of lisergine acid

Info

Publication number
BG33885A3
BG33885A3 BG033012A BG3301276A BG33885A3 BG 33885 A3 BG33885 A3 BG 33885A3 BG 033012 A BG033012 A BG 033012A BG 3301276 A BG3301276 A BG 3301276A BG 33885 A3 BG33885 A3 BG 33885A3
Authority
BG
Bulgaria
Prior art keywords
acid
lisergine
amids
producing
proven
Prior art date
Application number
BG033012A
Other languages
Bulgarian (bg)
English (en)
Inventor
Erzsebet Mago
Jozsef Borsi
Laszlo Tardos
Ildiko Kiraly
Sandor Elek
Istvan Elekes
Original Assignee
Неизвестен
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Неизвестен filed Critical Неизвестен
Publication of BG33885A3 publication Critical patent/BG33885A3/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D457/00—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid
    • C07D457/04—Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula:, e.g. lysergic acid with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 8
    • C07D457/06—Lysergic acid amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
BG033012A 1975-04-24 1976-04-23 Method for producing the amids of lisergine acid BG33885A3 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU75GO00001309A HU172649B (hu) 1975-04-24 1975-04-24 Sposob poluchenija novykh biologicheski aktivnykh lizergamidov

Publications (1)

Publication Number Publication Date
BG33885A3 true BG33885A3 (en) 1983-05-16

Family

ID=10996791

Family Applications (1)

Application Number Title Priority Date Filing Date
BG033012A BG33885A3 (en) 1975-04-24 1976-04-23 Method for producing the amids of lisergine acid

Country Status (21)

Country Link
US (1) US4101552A (sv)
JP (1) JPS5940833B2 (sv)
AT (1) AT352297B (sv)
AU (1) AU503465B2 (sv)
BE (1) BE841049A (sv)
BG (1) BG33885A3 (sv)
CA (1) CA1081215A (sv)
CH (1) CH619708A5 (sv)
CS (1) CS194758B2 (sv)
DD (1) DD125487A5 (sv)
DE (1) DE2617738A1 (sv)
DK (1) DK144127C (sv)
FR (1) FR2308366A1 (sv)
GB (1) GB1512874A (sv)
HU (1) HU172649B (sv)
IL (1) IL49447A (sv)
NL (1) NL7604266A (sv)
PL (1) PL102509B1 (sv)
SE (1) SE425783B (sv)
SU (1) SU604493A3 (sv)
YU (1) YU42144B (sv)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2802023A1 (de) * 1977-01-28 1978-08-03 Sandoz Ag Neue ergotderivate, ihre herstellung und verwendung
GB1584464A (en) * 1977-04-19 1981-02-11 Farmaceutici Italia Ergot alkaloids
IT1192260B (it) * 1977-07-05 1988-03-31 Simes Derivati di ergoline-2-tioeteri e loro solfossidi
AU553809B2 (en) * 1981-07-21 1986-07-31 Farmitalia Carlo Erba S.P.A. Ergoline derivatives
CH653333A5 (de) * 1981-11-04 1985-12-31 Sandoz Ag N-substituierte ergolin- und 9,10-didehydroergolinderivate, ihre herstellung und sie enthaltende arzneimittel.
YU254782A (en) * 1981-12-18 1986-10-31 Schering Ag Process for making new ergot anilides
DE3362248D1 (en) * 1982-04-13 1986-04-03 Erba Farmitalia Ergoline derivatives, process for producing the ergoline derivatives and pharmaceutical compositions containing them
GB2173189B (en) * 1985-02-21 1988-04-27 Maruko Pharmaceutical Co Ergoline derivatives and salts thereof and pharmaceutical compositions thereof
US4910206A (en) * 1986-07-14 1990-03-20 Sandoz Pharmaceuticals Corp. 5-hetero-or aryl-substituted-imidazo(2,1-a)isoquinolines and their use as PAF receptor antagonists
US4902691A (en) * 1988-12-19 1990-02-20 Eli Lilly And Company Heteroalkylamides of (8-β)-1-alkyl-6-(substituted)ergolines useful for blocking 5HT2 receptors
BR112017015487A2 (pt) * 2015-01-20 2018-01-30 Xoc Pharmaceuticals Inc Composto; composição; método de tratamento e/ou prevenção de enxaqueca, als, doença de alzheimer, doença de parkinson, distúrbios extrapirimidais, depressão, náusea, êmese, síndrome das pernas inquietas, insônia, agressão, doença de huntington, doença cardiopulmonar, fibrogênese, hipertensão arterial pulmonar, ansiedade, dependências a drogas, distonia, parassonia ou hiperlactinemia em um indivíduo; métodos de agonização dos receptores d2, 5-ht1d, 5-ht1a e 5-ht2c, em um indivíduo; método de antagonização do receptor d3 em um indivíduo; métodos de agonização seletiva dos receptores 5 -ht1d, e 5-ht2c, método de fornecimento de atividade de antagonista funcional no receptor 5 -ht2b ou no receptor 5-ht7, ou em ambos, em um indivíduo; método de fornecimento de atividade de antagonista funcional nos receptores adrenérgicos em um indivíduo
WO2018223065A1 (en) 2017-06-01 2018-12-06 Xoc Pharmaceuticals, Inc. Ergoline derivatives for use in medicine
KR20230024378A (ko) 2020-06-12 2023-02-20 벡클리 싸이테크 리미티드 5-메톡시-n, n-디메틸트립타민의 벤조에이트 염을 포함하는 조성물
GB202212116D0 (en) 2022-08-19 2022-10-05 Beckley Psytech Ltd Pharmaceutically acceptable salts and Compositions thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2090430A (en) * 1937-08-17 Lysergic acid amides and process for
US2736728A (en) * 1954-12-06 1956-02-28 Lilly Co Eli Preparation of lysergic acid amides
DE1040560B (de) * 1955-11-21 1958-10-09 Lilly Co Eli Verfahren zur Herstellung von Lysergsaeureamiden
US2997470A (en) * 1956-03-05 1961-08-22 Lilly Co Eli Lysergic acid amides
GB1112909A (en) * 1964-09-15 1968-05-08 Sandoz Ltd Ergoline derivatives
CH496010A (de) * 1967-04-20 1970-09-15 Richter Gedeon Vegyeszet Verfahren zur Herstellung von d-Lysergsäureamiden
SE396753B (sv) * 1970-05-18 1977-10-03 Richter Gedeon Vegyeszet Analogiforfarande for framstellning av en forening tillhorande dihydrolysergsyraserien
IL41409A (en) * 1972-02-04 1977-04-29 Richter Gedeon Vegyeszet Lysergic acid amides and process for their preparation
HU169073B (sv) * 1974-05-28 1976-09-28

Also Published As

Publication number Publication date
DK184176A (da) 1976-10-25
GB1512874A (en) 1978-06-01
FR2308366A1 (fr) 1976-11-19
AT352297B (de) 1979-09-10
SE425783B (sv) 1982-11-08
CA1081215A (en) 1980-07-08
CS194758B2 (en) 1979-12-31
DE2617738A1 (de) 1976-11-18
SU604493A3 (ru) 1978-04-25
PL102509B1 (pl) 1979-04-30
IL49447A (en) 1979-11-30
SE7604724L (sv) 1976-10-25
JPS51131898A (en) 1976-11-16
JPS5940833B2 (ja) 1984-10-03
YU42144B (en) 1988-06-30
ATA286376A (de) 1979-02-15
BE841049A (fr) 1976-10-25
DK144127B (da) 1981-12-14
US4101552A (en) 1978-07-18
DE2617738C2 (sv) 1989-10-19
DD125487A5 (sv) 1977-04-20
AU1328376A (en) 1977-10-27
HU172649B (hu) 1978-11-28
NL7604266A (nl) 1976-10-26
CH619708A5 (sv) 1980-10-15
FR2308366B1 (sv) 1978-12-08
YU103176A (en) 1982-08-31
IL49447A0 (en) 1976-06-30
AU503465B2 (en) 1979-09-06
DK144127C (da) 1982-06-01

Similar Documents

Publication Publication Date Title
BG28259A3 (en) Method of obtaining of n- (4- piperidinyl)- n- phenylamids and carbamites
BG28065A4 (en) Method of obtaining of 2-phenyl-3-aroylbenzothiophenes
BG34336A3 (en) Method for obtaining derivates of phtalazine-4-yl-acetic acid
BG28061A3 (en) Method of obtaining of hexahydrodibenzopyranones
BG31945A3 (en) Method for obtaining of 4- acylamino- phenyl- ethanolamines
BG36044A3 (en) Method for preparing piperazine derivatives
BG34187A3 (en) Method for obtaining delta above 15- steroids
BG33885A3 (en) Method for producing the amids of lisergine acid
BG33006A3 (en) Method for obtaining of n- (perfluoracil)- n- phosphonomethyl- glycine compounds
BG33585A3 (bg) Нов метод за получаване на азини
BG28068A3 (en) Method of obtaining of 3-chlorcephalosporines
BG34185A3 (en) Method for obtaining pepperazinilpyrazine derivative
BG28072A4 (en) Method of obtaining of 1-substitvated canamyzine derivatives
BG34036A3 (en) A method of obtaining propargyl- 2- phenylamino- imidazolines- (2) and their acid salts
BG31070A3 (en) Method for obtaining of 11- dexoxy- 16- aryl- w- tetranoprostagine
BG33275A3 (en) Method for obtaining the benzophenon derivatives
BG30778A3 (en) Method for obtaining of eburnamenine derivatives
BG34038A3 (en) A method of obtaining 7- substituted aminoacetamidooxadetiacephalosprorines
BG30927A3 (en) Method for obtaining of trans- 4- alpha- phenyl- octahydro- 1h- 2- pyridine
BG30475A3 (en) Method for obtaining of deposteroid esters
BG35466A3 (en) Method for preparing derivatives of clavulanic acid
BG31503A3 (en) Method for obtaining the derivatives of octahjdroindolhinolzine
BG30021A3 (en) Method for obtaining of imidazoisohinolin- dion
BG28845A3 (en) Method of obtaining of n- alkyldiphenylamines
BG28415A4 (en) Method of obtaining of 9-hydroxyoctahydrobenzo (c) hynolines